Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of the Association Between DNA Methylation and Shortened Survival in Patients With Advanced Colorectal Cancer Treated With 5-FU/Oxaliplatin-Based Regimens in E3200.

Trial Profile

Evaluation of the Association Between DNA Methylation and Shortened Survival in Patients With Advanced Colorectal Cancer Treated With 5-FU/Oxaliplatin-Based Regimens in E3200.

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Jun 2014

At a glance

  • Drugs Bevacizumab (Primary) ; Carboplatin; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin; Paclitaxel
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 May 2009 New source identified and integrated (ClinicalTrials.gov record NCT00897754).
    • 28 Jan 2008 Broad-label approval was based on the results of this study and NO16966 [see 700003183].
    • 26 Apr 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top